The Ranger Drug-Coated Balloon was approved today (10/2) by the U.S. Food and Drug Administration (FDA) for the treatment of patients with peripheral artery disease, a disease that affects 200 million people. The disease is characterized by a plaque build up in the arteries that affects blood flow to the limbs. The device is expected to launch immediately into the United States and will allow doctors better access to data driven devices with statistically proven efficacy.

Learn more here.

More on: